Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Apyx Medical (APYX) Leases (2019 - 2026)

Apyx Medical filings provide 10 years of Leases readings, the most recent being $4.2 million for Q4 2025.

  • On a quarterly basis, Leases rose 8687.5% to $4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 million, a 8687.5% increase, with the full-year FY2025 number at $4.2 million, up 8687.5% from a year prior.
  • Leases hit $4.2 million in Q4 2025 for Apyx Medical, down from $4.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $5.2 million in Q4 2023 to a low of $38000.0 in Q2 2025.
  • Median Leases over the past 5 years was $179000.0 (2021), compared with a mean of $1.7 million.
  • The widest YoY moves for Leases: up 8687.5% in 2025, down 99.23% in 2025.
  • Apyx Medical's Leases stood at $121000.0 in 2021, then fell by 4.96% to $115000.0 in 2022, then skyrocketed by 4388.7% to $5.2 million in 2023, then tumbled by 99.07% to $48000.0 in 2024, then skyrocketed by 8687.5% to $4.2 million in 2025.
  • The last three reported values for Leases were $4.2 million (Q4 2025), $4.3 million (Q3 2025), and $38000.0 (Q2 2025) per Business Quant data.